The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases
Recent investigations have shown that different conditions such as diet, the overuse of antibiotics or the colonization of pathogenic microorganisms can alter the population status of the intestinal microbiota. This modification can produce a change from homeostasis to a condition known as imbalance...
Main Authors: | Pablo Alagón Fernández del Campo, Alejandro De Orta Pando, Juan Ignacio Straface, José Ricardo López Vega, Diego Toledo Plata, Sebastian Felipe Niezen Lugo, Diego Alvarez Hernández, Tomás Barrientos Fortes, Laila Gutiérrez-Kobeh, Sandra Georgina Solano-Gálvez, Rosalino Vázquez-López |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/7/2/33 |
Similar Items
-
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
by: Shaghayegh Baradaran Ghavami, et al.
Published: (2021-07-01) -
Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
by: Katarzyna Akutko, et al.
Published: (2021-06-01) -
Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
by: Shaghayegh Baradaran Ghavami, et al.
Published: (2020-08-01) -
A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases
by: Bhagavathi Sundaram Sivamaruthi
Published: (2018-01-01) -
Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study
by: Manuel Pabón-Carrasco, et al.
Published: (2020-08-01)